PATENT CLAIM ANALYSIS

Application Number: 16319951
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["544", "277000"]

Abstract:
There are provided substituted purine and 3-deazapurine analogues, which modulate the activity of Choline Kinase (ChoK). The compounds of this invention are therefore useful in treating diseases caused by an altered choline metabolism, such as cancer, cell proliferative disorders, infectious diseases of different origin, immune-related disorders and neurodegenerative disorders. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds.

Claim (Index 16):
The method according to  claim 12 , wherein said mammal in need thereof is human.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.52632
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12678806', '13377854', '14874513', '15335619', '13780557']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7914144719403293
- 35 USC 102 Novelty (BERT): 0.5235460376384584
- Combined Prediction Score: 0.7646276285101422
- Mean Citation Score: 270.152288
- Max Citation Score: 281.84406
- Similarity Product: 135.87625135749582

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test